BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17244030)

  • 1. Expression of BMI-1 in normal skin and inflammatory and neoplastic skin lesions.
    Reinisch CM; Uthman A; Erovic BM; Pammer J
    J Cutan Pathol; 2007 Feb; 34(2):174-80. PubMed ID: 17244030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maspin expression in normal skin and usual cutaneous carcinomas.
    Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
    Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p63 expression in normal skin and usual cutaneous carcinomas.
    Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
    J Cutan Pathol; 2002 Oct; 29(9):517-23. PubMed ID: 12358808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncoprotein BMI-1 induces the malignant transformation of HaCaT cells.
    Wang Q; Li WL; You P; Su J; Zhu MH; Xie DF; Zhu HY; He ZY; Li JX; Ding XY; Wang X; Hu YP
    J Cell Biochem; 2009 Jan; 106(1):16-24. PubMed ID: 19021148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival.
    Kang MK; Kim RH; Kim SJ; Yip FK; Shin KH; Dimri GP; Christensen R; Han T; Park NH
    Br J Cancer; 2007 Jan; 96(1):126-33. PubMed ID: 17179983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis.
    Lee K; Adhikary G; Balasubramanian S; Gopalakrishnan R; McCormick T; Dimri GP; Eckert RL; Rorke EA
    J Invest Dermatol; 2008 Jan; 128(1):9-17. PubMed ID: 17625597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
    Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
    J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocyto- and histochemical profiling of nucleostemin expression: marker of epidermal stem cells?
    Lacina L; Smetana K; Dvoránková B; Stork J; Plzáková Z; Gabius HJ
    J Dermatol Sci; 2006 Nov; 44(2):73-80. PubMed ID: 17000083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
    Zhang X; Egawa K; Xie Y; Ihn H
    Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p53 protein in benign and malignant epidermal pathologic conditions.
    Helander SD; Peters MS; Pittelkow MR
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):741-8. PubMed ID: 8227547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parakeratosis in skin is associated with loss of inhibitor of differentiation 4 via promoter methylation.
    Ruchusatsawat K; Wongpiyabovorn J; Protjaroen P; Chaipipat M; Shuangshoti S; Thorner PS; Mutirangura A
    Hum Pathol; 2011 Dec; 42(12):1878-87. PubMed ID: 21663940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
    Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
    Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal fatty-acid-binding protein in psoriasis, basal and squamous cell carcinomas: an immunohistological study.
    Masouyé I; Saurat JH; Siegenthaler G
    Dermatology; 1996; 192(3):208-13. PubMed ID: 8726632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin.
    Lymboussaki A; Kaipainen A; Hatva E; Västrik I; Jeskanen L; Jalkanen M; Werner S; Stenbäck F; Alitalo R
    Br J Cancer; 1996 Jun; 73(11):1347-55. PubMed ID: 8645578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas.
    Kim HS; Shin MS; Cheon MS; Kim JW; Lee C; Kim WH; Kim YS; Jang BG
    PLoS One; 2017; 12(3):e0174565. PubMed ID: 28346486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hurpin, a serine proteinase inhibitor, in normal and pathological skin: overexpression and redistribution in psoriasis and cutaneous carcinomas.
    Moussali H; Bylaite M; Welss T; Abts HF; Ruzicka T; Walz M
    Exp Dermatol; 2005 Jun; 14(6):420-8. PubMed ID: 15885077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Akt and mTOR in CD34+/K15+ keratinocyte stem cells and skin tumors during multi-stage mouse skin carcinogenesis.
    Affara NI; Trempus CS; Schanbacher BL; Pei P; Mallery SR; Bauer JA; Robertson FM
    Anticancer Res; 2006; 26(4B):2805-20. PubMed ID: 16886599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gli1 protein is expressed in basal cell carcinomas, outer root sheath keratinocytes and a subpopulation of mesenchymal cells in normal human skin.
    Ghali L; Wong ST; Green J; Tidman N; Quinn AG
    J Invest Dermatol; 1999 Oct; 113(4):595-9. PubMed ID: 10504446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases.
    Piepkorn M
    Am J Dermatopathol; 1996 Apr; 18(2):165-71. PubMed ID: 8739992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors.
    Kanoh M; Amoh Y; Sato Y; Katsuoka K
    Eur J Dermatol; 2008; 18(5):518-23. PubMed ID: 18693153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.